Benign Prostatic Hyperplasia: Clinical Trials

7 trials for Benign Prostatic Hyperplasia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 terminated. 7 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 37Terminated 7

Follow Benign Prostatic Hyperplasia: new trials by email Literature Review of Benign Prostatic Hyperplasia trials Research Report on Benign Prostatic Hyperplasia

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Results of Selective Prostatic Arterial Embolization in Patients With Indwelling Urinary Catheter Due to Benign Prostatic Hyperplasia Refractory to Medical Treatment.
Prostatic arterial embolization using BeadBlock (Terumo) - Benign Prostatic Hyperplasia
Phase 3TerminatedUniversity Hospital, Rouen22014-05-012015-07-30
Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2)
Finasteride, Tamsulosin, Finasteride-matching placebo - Benign Prostatic Hyperplasia
Phase 3TerminatedMerck Sharp & Dohme LLC12013-08-012018-08-29
JALYN for Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
Jalyn, Placebo - Benign Prostatic Hyperplasia, Chronic Prostatitis
Phase 3TerminatedDr. J. Curtis Nickel12013-04-012014-10-22
MCS in Treating Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia
MCS, Placebo - Benign Prostatic Hyperplasia
Phase 3TerminatedHealth Ever Bio-Tech Co., Ltd.852007-07-012011-12-14
A Clinical Trial Comparing Laser TURP With and Without Dutasteride.
Dutasteride (Avodart), Placebo - Benign Prostatic Hyperplasia
Phase 3TerminatedNorthwestern University42006-10-012015-10-28
Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Lonidamine - Benign Prostatic Hyperplasia, Enlarged Prostate
Phase 3TerminatedThreshold Pharmaceuticals4802005-06-012009-04-29
Minimally Invasive Surgical Therapy for BPH
Transurethral Microwave Thermotherapy (TUMT), Transurethral Needle Ablation (TUNA) Therapy, Finasteride and Alfuzosin - Benign Prostatic Hyperplasia
Phase 3TerminatedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)492004-04-012010-01-14

Narrower conditions

Prostatic Hyperplasia (7)  ·  Hyperplasia (1)  ·  Lower Urinary Tract Symptoms (1)

Broader conditions

Genital Diseases (7)  ·  Genital Diseases, Male (7)  ·  Male Urogenital Diseases (7)  ·  Prostatic Diseases (7)  ·  Urogenital Diseases (7)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Pathologic Processes (1)  ·  Signs and Symptoms (1)  ·  Urological Manifestations (1)

Interventions

Dutasteride (2)  ·  Finasteride (2)  ·  Tamsulosin (2)  ·  Therapeutics (1)  ·  Transurethral Resection of Prostate (1)  ·  alfuzosin (1)  ·  lonidamine (1)

Sponsors

Dr. J. Curtis Nickel (1)  ·  Health Ever Bio-Tech Co., Ltd. (1)  ·  Merck Sharp & Dohme LLC (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  Northwestern University (1)  ·  Threshold Pharmaceuticals (1)  ·  University Hospital, Rouen (1)

Countries

Canada (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Poland (1)  ·  Taiwan (1)  ·  United States (1)

Top investigators

J. Curtis Nickel, MD FRCSC (1)  ·  Kevin T. McVary, MD (1)  ·  Peter Alken, MD (1)  ·  Reginald Bruskewitz, M.D. (1)  ·  Yeong-Shiau Pu, MD, PhD (1)

NIH funding

U01DK060817 (1)